A before-after implementation trial of smoking cessation guidelines in hospitalized veterans by Katz, David et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
Implementation Science
Open Access Study protocol
A before-after implementation trial of smoking cessation guidelines 
in hospitalized veterans
David Katz*1,2, Mark Vander Weg1,2, Steve Fu3, Allan Prochazka4, 
Kathleen Grant5, Lynne Buchanan6, David Tinkelman7, 
Heather Schacht Reisinger1,2, John Brooks8, Stephen L Hillis2, Anne Joseph10 
and Marita Titler2,9
Address: 1Department of Medicine, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, IA, USA, 2Center for Research in 
the Implementation of Innovative Strategies in Practice, Iowa City VA Medical Center, University of Iowa, Iowa City, IA, USA, 3Center for Chronic 
Disease and Outcomes Research, Minneapolis VA Medical Center, Minneapolis, MN, USA, 4Department of Medicine, VA Eastern Colorado Health 
Care System, Denver, CO, USA, 5Department of Psychiatry, VA Nebraska-Western Iowa Health Care System, Omaha, NE, USA, 6The College of 
Nursing, University of Nebraska, Omaha, NE, USA, 7Health Initiatives Program, National Jewish Health, Denver, CO, USA, 8College of Pharmacy, 
University of Iowa Carver College of Medicine, University of Iowa, Iowa City, IA, USA, 9College of Nursing, University of Iowa Carver College of 
Medicine, University of Iowa, Iowa City, IA, USA and 10Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Email: David Katz* - david-katz@uiowa.edu; Mark Vander Weg - mark-vanderweg@uiowa.edu; Steve Fu - Steven.Fu@med.va.gov; 
Allan Prochazka - Allan.Prochazka@va.gov; Kathleen Grant - Kathleen.Grant2@va.gov; Lynne Buchanan - lbuchanan@unmc.edu; 
David Tinkelman - TinkelmanD@NJC.ORG; Heather Schacht Reisinger - Heather.Reisinger@va.gov; John Brooks - john-brooks@uiowa.edu; 
Stephen L Hillis - Stephen.Hillis@va.gov; Anne Joseph - amjoseph@umn.edu; Marita Titler - mtitler@umich.edu
* Corresponding author    
Abstract
Background: Although most hospitalized smokers receive some form of cessation counseling
during hospitalization, few receive outpatient cessation counseling and/or pharmacotherapy
following discharge, which are key factors associated with long-term cessation. US Department of
Veterans Affairs (VA) hospitals are challenged to find resources to implement and maintain the kind
of high intensity cessation programs that have been shown to be effective in research studies. Few
studies have applied the Chronic Care Model (CCM) to improve inpatient smoking cessation.
Specific objectives: The primary objective of this protocol is to determine the effect of a nurse-
initiated intervention, which couples low-intensity inpatient counseling with sustained proactive
telephone counseling, on smoking abstinence in hospitalized patients. Key secondary aims are to
determine the impact of the intervention on staff nurses' attitudes toward providing smoking
cessation counseling; to identify barriers and facilitators to implementation of smoking cessation
guidelines in VA hospitals; and to determine the short-term cost-effectiveness of implementing the
intervention.
Design: Pre-post study design in four VA hospitals
Participants: Hospitalized patients, aged 18 or older, who smoke at least one cigarette per day.
Intervention:  The intervention will include: nurse training in delivery of bedside cessation
counseling, electronic medical record tools (to streamline nursing assessment and documentation,
to facilitate prescription of pharmacotherapy), computerized referral of motivated inpatients for
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proactive telephone counseling, and use of internal nursing facilitators to provide coaching to staff
nurses practicing in non-critical care inpatient units.
Outcomes:  The primary endpoint is seven-day point prevalence abstinence at six months
following hospital admission and prolonged abstinence after a one-month grace period. To
compare abstinence rates during the intervention and baseline periods, we will use random effects
logistic regression models, which take the clustered nature of the data within nurses and hospitals
into account. We will assess attitudes of staff nurses toward cessation counseling by questionnaire
and will identify barriers and facilitators to implementation by using clinician focus groups. To
determine the short-term incremental cost per quitter from the perspective of the VA health care
system, we will calculate cessation-related costs incurred during the initial hospitalization and six-
month follow-up period.
Trial number: NCT00816036
Background
Smoking remains the leading preventable cause of death
in the US, accounting for approximately one of every five
deaths (420,000 people) each year [1]. The burden of
tobacco-related illnesses in the US Veterans Administra-
tion (VA) population is particularly high, and the preva-
lence of smoking is estimated to be 21 to 40% higher in
veterans than in the general population [2,3]. Hospitaliza-
tion has been identified as a 'teachable moment' for many
smokers [4]. Nearly all VA hospitals have become smoke-
free, and can provide a supportive environment in which
smokers are not exposed to their usual external cues to
smoke [5]. Moreover, approximately 50% of hospitalized
smokers are ready to quit within 30 days [6], and 80% are
willing to discuss smoking cessation with a counselor dur-
ing hospitalization [7]. Data from the External Peer
Review Program (a contracted review of the quality of VA
care) suggest that over 90% of VA smokers receive advice
to stop smoking during hospitalization; however, the
quality and scope of such counseling is unclear.
Although adherence to smoking cessation guidelines has
been actively promoted since 1997, VA hospitals typically
do not facilitate cessation interventions in hospitalized
smokers by providing inpatient staff with appropriate
education, resources, and performance feedback, as rec-
ommended by US Public Health Service (USPHS) guide-
lines [1]. Additional institutional barriers in the VA
include: a specialty focus on smoking cessation coun-
seling in the majority of VA hospitals, in which most
patients are referred to a multi-session smoking cessation
program [8,9]; lack of continuity of care after discharge,
with limited opportunities to promote continued absti-
nence [5]; and variable policies and practices in the dis-
pensing of drug therapy for cessation that may contribute
to the under use of effective pharmacotherapy [10]. With
regard to referral, few hospitalized smokers attend smok-
ing cessation classes or clinics after discharge [11]. In the
VA, the primary reasons that patients do not follow up are:
access problems (36%), lack of commitment to quitting
(35%), and unhappiness with the group format (14%),
which is the primary counseling format offered in many
VA hospitals [12]. In addition, the delay between referral
and an initial smoking cessation appointment can be crit-
ical [8], as a large proportion of smokers relapse within
one week of quitting [13,14].
VA hospitals are challenged to find resources to imple-
ment the types of programs shown to be effective in
research studies. Effective cessation programs typically
include a high-intensity inpatient component (≤ 1 hour of
face-to-face counseling) combined with sustained relapse
prevention measures (≥ 4 weeks of counseling) and phar-
macotherapy [11,15-17]. Much less is known about the
effectiveness of 'hybrid' interventions that combine low-
intensity inpatient counseling (defined as a single session
lasting 10 minutes or less)[1] with sustained relapse pre-
vention delivered by non-research personnel. Such strate-
gies may be more realistic in practice than high-intensity
interventions, as they place fewer demands on inpatient
staff and are consistent with the 'ask, advise, and refer'
model of cessation counseling that has been promoted in
primary care [18].
Study aims
The proposed study will test an implementation interven-
tion to increase quit rates in hospitalized smokers in non-
critical care settings by facilitating staff nurses' delivery of
recommended smoking cessation services and reducing
patient barriers to participation in cessation counseling.
Of all the members of the inpatient team, VA staff nurses
(including registered nurses (RNs) and licensed practical
nurses (LPNs)) are best positioned to deliver a brief smok-
ing cessation intervention because of their ready access to
patients and education in patient education and coun-
seling. Several controlled trials have demonstrated that
nurse-delivered counseling can increase quit rates in hos-
pitalized patients [19-22]. Although most of these trialsImplementation Science 2009, 4:58 http://www.implementationscience.com/content/4/1/58
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have employed high-intensity interventions [11], low
intensity counseling by staff nurses can also yield favora-
ble results [23].
Thus, the primary aim of this practical clinical trial is to:
1. Determine the effect of a nurse-initiated intervention,
which couples low intensity inpatient counseling with
sustained proactive telephone counseling, on smoking
abstinence in hospitalized patients.
Hypothesis 1a: Smoking cessation rates at three and six
month follow-up, as measured by seven-day point preva-
lence abstinence (PPA) will be greater for intervention
patients than usual care patients.
Hypothesis 1b: Intervention patients will be more likely
to receive prescriptions for recommended pharmacother-
apy for smoking cessation and referral to telephone coun-
seling, compared to usual care patients.
To gain insight into mechanisms promoting the adoption
of recommended practices by nurses and to determine the
relative economic value of the intervention, key secondary
aims are to:
1. Determine the impact of the intervention on nurses'
attitudes toward and self-efficacy for providing smoking
cessation counseling.
Hypothesis 2: Nurses attitudes toward cessation coun-
seling and self-efficacy in providing such counseling will
increase after being exposed to the intervention.
2. Identify barriers and facilitators to implementation of
smoking cessation guidelines in VA hospitals and learn
how to tailor the intervention to specific sites.
3. Determine the short-term cost-effectiveness of this
implementation intervention.
Methods
Study design
This study is a before-after trial (with each site serving as
its own control) in smokers who are hospitalized on the
medical wards of four VA hospitals (Figure 1). After a six-
month baseline period of enrollment, the research team
will conduct focus groups of clinical staff at each site,
adapt the strategy for guideline implementation, and train
clinical staff at each site. A new cohort of study patients
will be enrolled over the subsequent six-month interven-
tion period. Staggering the timing of intervention across
sites will allow us to collect concurrent control data for
three of the four study sites during intervention; this will
enable detection of system-wide trends in the delivery of
cessation counseling, measurement reactivity, and other
potential confounding factors within each period (except
the final period)[24,25]. We considered cluster randomi-
zation by hospital, but the cost of conducting such a trial
was not feasible due to budgetary constraints (as at least
four sites per comparison group are typically required)
[26].
Study sites
We have selected four VA hospitals in the upper Midwest
and Rocky Mountain region for this trial based on the fol-
lowing criteria: at least 150 general medical admissions
monthly (to support recruitment targets), and support
from nursing, pharmacy, and information technology
(IT) leaders for this project. The variability in delivery of
smoking cessation counseling across these study sites will
enhance external validity, and may provide insight into
the intervention's effectiveness under different baseline
conditions (Table 1).
Screening and recruitment
A study site research assistant (RA) who is not associated
with the intervention will screen all medical admissions
to determine eligibility by medical record review. The
study sample will include general medical inpatients,
aged 18 or older, who smoke at least one cigarette per day
on average, regardless of their willingness to quit smok-
ing. Current smokers transferred from intensive care units
(or other monitored beds) to a general medical ward will
be eligible. Exclusion criteria include: hospitalization for
less than 24 hours (e.g., patients admitted for overnight
observation); acute medical decompensation (e.g., acute
respiratory failure requiring intubation, cardiac arrest,
septic shock); altered mental status; unstable psychiatric
disorder (e.g., acute psychosis); dementia; communica-
tion barrier (unable to speak English, hard of hearing,
aphasic); pregnancy; and terminal illness (<12 month life
Schematic of Study Design Figure 1
Schematic of Study Design.
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expectancy). No patient will be included unless they pro-
vide informed consent and agree to be contacted by tele-
phone during follow-up.
Intervention: Application of the Chronic Care Model 
(CCM) in smoking cessation
The VA/Department of Defense clinical practice guideline
for the management of tobacco use recommends that hos-
pitalized patients should have smoking status docu-
mented in the medical record, should be advised to quit,
should receive smoking cessation medication and coun-
seling, and should be referred for continuing support
upon discharge [27]. The challenges in designing an effec-
tive inpatient smoking cessation program are to find effi-
cient strategies that empower clinicians to capitalize on
opportunities for counseling inherent in the hospital set-
ting and arrange for comprehensive smoking cessation
therapy that extends beyond the hospital stay. In addition,
many hospitalized smokers have reduced capacity to
engage in discussions about smoking cessation because of
medical instability, altered mental status, and the psycho-
logical stresses of acute illness [6]. Given the relapsing and
remitting course of tobacco dependence, the CCM pro-
vides a framework for addressing these challenges and for
improving patient outcomes [28-30], as discussed below.
Table 1: Description of VA study hospitals
Hospital A Hospital B Hospital C Hospital D
Patient characteristics
Age, mean 62.9 65.1 62.7 60.4
Gender, % male 97 96 95 94
Race, % white 97 80 85 86
Income ($), mean 21,349 26,287 20,500 19,414
General medical wards
Annual number of admissions, n 2,988 4,388 2,701 2,806
Total number of nursing staff 42 72 60 52
% Registered nurses (RN)* 67 68 73 58
Average daily census (across wards), n 29 62 33 42
Average nursing hours per patient day 6.2 7.13 8.31 7.34
Smoking cessation services**
Responsible division Mental health Mental health Mental health Primary care
No. of consults per month 50 60 65 30
How often do new patients start program? 1/month 1/week NS 1/week
No. of individual counseling sessions per typical course of therapy 3 NS 2 4
Program includes group counseling Y Y N Y
Can patients receive pharmacotherapy without enrollment in smoking cessation 
program?
YYN Y
Any use of telemedicine to provide cessation therapy? Y N Y N
*Source: VHA Support Service Center. http://vssc.med.va.gov (accessed 6/13/07). Nurse staffing was estimated from local data.
**Source: Office of the Assistant Deputy Undersecretary for Health for Policy and Planning. Veterans Health Administration. Smoking and Tobacco 
Use Cessation Report 2005. http://vaww.va.gov/haig/smoking/STUC_2005.pdf (last accessed 1 December 2006).Implementation Science 2009, 4:58 http://www.implementationscience.com/content/4/1/58
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Practice redesign and nurse training
For nurses, the delivery of cessation guidelines is poten-
tially influenced by practice-related factors, including the
perceived ability to offer advice (e.g., time pressure, urgen-
cies of acute care, cessation skills) [31,32], perceived sup-
port of clinical leadership [33], perceived autonomy [34],
and attitudes toward cessation counseling. In one survey
of 369 general practice nurses, 65% believed that advice
from a nurse to quit smoking was ineffective [35]. Like
physicians, nurses may not perceive smoking cessation to
be a high priority in clinical care or believe that they have
the time to perform recommended preventive services,
particularly with pressures to reduce length of stay. Our
training strategy will seek to: improve staff nurses' atti-
tudes toward the delivery of smoking cessation interven-
tions; improve nurses' self-efficacy by providing an
opportunity to practice cessation counseling and critical
thinking skills with colleagues (using role-play, case stud-
ies, and clinical simulations); and use peer leaders to pro-
vide informal coaching and feedback. During an initial
30-minute, small group training session, members of the
research team will present baseline performance data on
cessation measures, demonstrate use of a computerized
nursing reminder and referral order for telephone coun-
seling in the VA computerized patient record system
(CPRS), and demonstrate principles of cessation coun-
seling [36,37]. Specifically, nurses will be trained on how
to assist patients in moving toward change and how to
recognize and manage resistance to behavior change
[38,39]. Nurses will also receive a pocket card showing the
smoking cessation algorithm (Figure 2) [40], standard-
ized messages to encourage quitting, and a list of strategies
for more challenging situations [23]. To supplement face-
to-face training, we will also develop an online tutorial
that includes case studies, video clips showing effective
stage-based counseling, and tips on using computerized
tools (nursing clinical reminder, quit line referral). In
practice, clinicians are generally more motivated to learn
if the training develops skills for solving practical prob-
lems and appeals to the clinician's sense of professional
identity (e.g., 'as a nurse, this is something that I should
do in my practice')[41].
Self-management support
Patient self-management support will consist of brief
inpatient counseling, pharmacotherapy, and follow-up
telephone counseling after discharge. Because of its con-
venience, telephone counseling has emerged as a popular
and effective alternative for delivery of self-management
support [42-45]. Moreover, the importance of sustained
relapse prevention has been demonstrated in systematic
reviews to be an essential component of smoking cessa-
tion [11,17,46]. In a recent randomized controlled trial
(RCT) of comprehensive telephone care versus routine
care in outpatient VA smokers, telephone care resulted in
a higher rate of six-month prolonged smoking abstinence
at 12-month follow-up (13 versus 4%, p < 0.001) and 30-
day abstinence from smoking (19% versus 13%, p =
Algorithm for Treating Tobacco Use and Dependence in Hospitals Figure 2
Algorithm for Treating Tobacco Use and Dependence in Hospitals.
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0.028) [47]. The linkage of patients to community
resources such as tobacco quit lines has also been advo-
cated as a sustainable strategy for providing in-depth ces-
sation counseling in busy practice settings [29].
The goals of brief inpatient counseling are to assess
patients' willingness to quit, motivate patients to abstain
from smoking during and after hospitalization, and assist
smokers in formulating a plan for continued abstinence
after discharge within five to ten minutes. At admission
(or as soon as the patient's acute medical condition has
stabilized), staff nurses will be trained to perform the 'five
A's' of smoking cessation counseling (ask, advise, assess,
assist, and arrange follow-up) [48], to assist patients in
moving toward change, and to recognize and manage
resistance to behavior change [38,39]. Staff nurses will
also be instructed in how to personalize the counseling for
patients' admission diagnoses and smoking-related
comorbidities, as smokers are more likely to quit if they
perceive that they are susceptible to the harmful effects of
smoking and perceive greater benefits of quitting)
[49,50]. In addition, staff nurses will assess interest in
receiving pharmacotherapy to help relieve nicotine with-
drawal symptoms.
Patients who express an interest in quitting will be shown
a 12-minute educational program on closed-circuit televi-
sion, produced specifically for hospitalized VA smokers,
and will receive a self-help guide to smoking cessation
('Clearing the Air: Quit Smoking Today', developed by the
National Cancer Institute) [51]. Similar educational aids
have been effectively used as an adjunct in counseling
hospitalized smokers [7,20], and can reduce the time
required for bedside counseling.
Nurses will be trained to electronically refer those patients
who are willing and ready to make a quit attempt for
proactive telephone counseling using a computerized
referral process, based on evidence that VA patients who
receive such counseling are more likely to quit [47].
Within 48 to 72 hours of discharge, a quit line counselor
will call to confirm the patient's interest in quitting, con-
gratulate the patient on his/her decision to stop smoking,
and provide encouragement to reinforce self-efficacy. For
those patients who are ambivalent about quitting, the
counselor will focus on increasing motivation to quit. For
those patients who remain committed to quitting, the
counselor will focus on relapse prevention [52].
Follow-up calls will be made using a relapse-sensitive
schedule (rather than at equal intervals) [13], with flexi-
bility to accommodate the patient's needs (up to seven
calls over three months) [47,53]. Telephone counselors
will document the initial and follow-up contacts in CPRS
using progress note templates for smoking cessation [54].
A final report summarizing events pertinent to the quit
attempt will also be entered into CPRS shortly after the
final counseling session (and will be mailed to the
patient's non-VA primary care clinician, if applicable).
Enabling bi-directional communication with primary care
will integrate the telephone counseling into the patient's
ongoing care [55,56]. We will also offer one additional
course of quit line counseling for relapsed smokers (i.e.,
those who fail in their initial quit attempt).
Clinical information system
Presenting clinical reminders in a clear, simple format and
coupling them with immediately actionable items is
essential to enhance their effectiveness [57,58]. Streamlin-
ing the presentation of reminders and integrating them
into the clinician's work flow is particularly important for
nurses, who typically move rapidly from patient to
patient, have little time to work through complex algo-
rithms, and need information to be readily available [59].
The study team will work with nurse managers and CPRS
clinical application specialists at each site to adapt the
nursing intake form to reflect the five A's with the end-user
in mind [60].
The smoking cessation template in CPRS will be designed
to allow staff nurses to select and print patient self-help
materials and to generate a consult for telephone care
counseling. 'Quick orders' for pharmacotherapy will
include recommended dosages for NRT, bupropion, and
second-line therapies (and a list of contraindications to
their use). The telephone care referral form will be
adapted from 'fax to quit' forms that have been used suc-
cessfully in primary care. System changes of this type can
increase clinicians' ability to help patients quit smoking
and their motivation to provide cessation counseling [18].
The research team at each site will query CPRS every two
months to determine the proportion of smokers given
assistance in quitting (referral for telephone counseling
ordered, pharmacotherapy ordered), and these process
measures will be presented to staff nurses during the inter-
vention period.
Organizational change
In the two months between the baseline and intervention
periods, we will conduct a focus group that includes one
or two of each of the following staff at each site: staff
nurse, nurse manager, resident, attending physician, phar-
macy director, and smoking cessation counselor (six to
nine members in total). The focus groups will ask partici-
pants to: describe local smoking cessation practices and
the 'smoking culture,' identify barriers and facilitators to
changing smoking cessation practices, and suggest strate-
gies that will facilitate change at the facility. Focus groups
will also allow the study team to examine work place cul-
ture, to understand group norms, and to elicit local per-Implementation Science 2009, 4:58 http://www.implementationscience.com/content/4/1/58
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spectives that may deviate from (or challenge)
conventional beliefs [61,62]. Summaries of the focus
groups will be provided to peer leaders (see below) and
will be used to adapt the strategy for guideline implemen-
tation to the local context [63-65].
With input from the director of nursing and nurse manag-
ers at each site, we will identify a peer leader on each med-
ical ward with the attributes of a change champion [59]
and the ability to model counseling skills (five A's), trou-
bleshoot issues during implementation, and assist in pre-
senting group feedback to nursing staff [40]. Peer leaders
will receive additional training in smoking cessation
counseling and in monitoring the practices of other staff
nurses by direct observation and medical record audit
(using spot checks). By influencing colleagues through
small group discussions, informal consultations, and
feedback, the peer leader can facilitate adherence to guide-
lines [66]. A nurse investigator on the study team will con-
tact each peer leader monthly during the intervention to
provide ongoing support and to identify and resolve bar-
riers to change. Notes on these conversations will also be
documented in the study log for each site. In one primary
care trial, the presence of a clinic champion was strongly
associated with referral of smokers to a quit line (OR =
3.4, 95% CI = 2.4-5.0)[67], and local champions have
emerged as key determinants of organizational innova-
tion [59,68,69].
Usual care
During the baseline period, nursing staff will be provided
with general information on the rationale for the current
study, but will not receive any specific training or addi-
tional resources for implementing the VA/Department of
Defense Clinical Practice Guideline in inpatient medical
units.
Data collection
During both the baseline and intervention periods,
patient data will be collected at four points in time: at
enrollment, just prior to discharge, and at three- and six-
month follow-up. Nursing staff will be surveyed just
before and after implementation of the study interven-
tion. To understand differences in performance of recom-
mended actions across sites, we will track the fidelity with
which clinician-focused elements of the intervention are
implemented (e.g., attendance of staff nurses at training
and feedback sessions, activity of peer leaders on each
ward). Similarly, to understand differences in quit rates
across sites, we will collect data regarding those elements
of the intervention that are implemented for each study
patient (e.g., delivery of bedside counseling, number of
doses of pharmacotherapy provided, and number of tele-
phone counseling sessions provided to patients referred to
the quit line). With regard to the latter, we will also esti-
mate the quit line connection rate by cross-referencing
CPRS referrals of study patients for telephone counseling
with actual quit line data [70].
Patient-level data
After obtaining informed consent, the RA will perform a
structured interview in current smokers to obtain more
detailed information on smoking history (pack-years,
number of quit attempts more than one day), other
tobacco use (e.g., spit tobacco), alcohol use, overall health
status, smoking-related medical comorbidities, readiness
to quit smoking [23], level of tobacco addiction [71], per-
ceived likelihood of staying off cigarettes after hospital
discharge [72], and social support for quitting [6].
Just prior to discharge, the RA will ask eligible smokers
whether they abstained from cigarettes during hospitali-
zation, and whether or not the hospital staff had per-
formed recommended smoking cessation counseling
during the hospital stay. Patients will also be asked to
specify whether they had received these services from their
nurse, physician, or other clinician (e.g., respiratory thera-
pist) [73]. Patient recall of advice to quit smoking has
been shown to be reasonably accurate in assessing per-
formance of guideline-recommended actions in clinical
practice (sensitivity 92%, specificity 82% for advice to
quit) [74].
At three- and six-month follow-up, research interviewers
will contact patients by telephone about their smoking
over seven days and 30 days prior to the interview (seven-
day and 30-day, PPA), any quit attempts (>24 hours)
since hospital discharge, and stage of change. At each fol-
low-up, we will also determine prolonged abstinence
(after a one-month grace period). All follow-up interview-
ers will be blinded to treatment assignment. Patients who
report abstinence at six-month follow-up will be mailed a
collection kit for salivary cotinine determination (with a
follow-up telephone reminder to return the sample). A
cutoff of 20 ng/ml will be used to determine abstinence,
as this threshold is associated with high sensitivity and
specificity (>90%) [75]. To calculate the biochemically
confirmed six-month quit rate, we will adjust the seven-
day PPA for the results of the cotinine analysis.
Nurse-level data
Pre- and post-intervention attitudes toward smoking ces-
sation counseling will be measured by a decisional bal-
ance questionnaire that includes 10 items that reflect
positive attitudes and 10 items that reflect negative atti-
tudes toward the delivery of smoking cessation assistance
[76]; in addition, we will also ask staff nurses about self-
efficacy and role satisfaction in helping patients stop
smoking [77]. As nursing performance can also be influ-
enced by job satisfaction and work environment [78], theImplementation Science 2009, 4:58 http://www.implementationscience.com/content/4/1/58
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survey will also assess perceptions of professional status
(using a seven-item subscale of the Index of Work Satisfac-
tion [79]) and staffing and resource adequacy (using a
four-item subscale of the Practice Environment Scale [80].
Summative evaluation of the intervention
At the end of the intervention period, we will conduct
semi-structured telephone interviews with approximately
32 patients. Within each site, we will randomly sample
two intervention patients from each of four stage of
change groups. Sampling for interviews will continue
until data are saturated (i.e., when no new data are forth-
coming in interviews within each site) [81]. The inter-
viewer will initially ask the patient to describe his/her
experiences with smoking and any conversations about
smoking with hospital staff during the index hospitaliza-
tion. Patients will then be asked to identify aspects of their
interactions with the inpatient team that were most help-
ful and most difficult with regard to smoking cessation.
Patients will also be asked about the transition to outpa-
tient care and any attempts to maintain abstinence follow-
ing hospital discharge. New questions will be added, and
the original questions will be refined to capture issues
emerging from the data as the interviews progress.
In order to evaluate the acceptability of the intervention to
nursing staff and its likelihood of being maintained, we
will conduct semi-structured, one-on-one interviews of
one peer leader and a random sample of five staff nurses
from each site (or until saturation is reached). The ques-
tions are designed to elicit stories from the staff nurses in
an effort to capture how the intervention was imple-
mented in practice [82]. In addition, they will be asked
about the usefulness of the intervention, their future plans
for using the intervention (or parts of it), and their sugges-
tions for further refinements. All telephone interviews will
be tape recorded, transcribed, and reviewed by the inter-
viewer for accuracy.
Sample size calculations
Based on the volume of admissions at each study hospital,
we plan to screen 7,548 potential subjects who are hospi-
talized on medical wards for greater than 24 hours during
the enrollment period at the four sites. Based on chart
review, we estimated smoking prevalence at each site
(weighted average = 23%, range 17 to 32%), and deter-
mined that approximately 80% of identified smokers will
be eligible to participate in the proposed trial. Assuming
that 84% of eligible patients consent to participate (based
on a recent VA smoking cessation study [47]), we would
expect 1,000 subjects to enroll in the study (500 baseline,
500 intervention). Pooling the control group data from
studies of general medical inpatients, we estimate a 12%
quit rate at six-months (seven-day PPA). Thus, a study
sample of 1,000 patients will have 83% power to detect a
seven percentage-point difference between periods in six-
month quit rates. This effect estimate is consistent with
that observed in prior hospital intervention trials that
employed a sustained relapse prevention component
[16,20,21]. Based on chart reviews at two study sites, we
estimate that 12 and 13% of inpatients during the base-
line period will be referred for cessation counseling and
will receive recommended pharmacotherapy, respec-
tively. The projected study sample will have 81 and 83%
power to detect a seven percentage-point difference in
these process measures, respectively. These power calcula-
tions are based on a hierarchical linear model, with nurse
treated as a random factor (and patient outcomes are clus-
tered within nurse); intracluster correlation (ICC) was
estimated to be 0.05 for assistance in quitting (which
includes offering of pharmacotherapy and arranging fol-
low-up), and 0.01 for abstinence, based on data from the
AHRQ Smoking Cessation Guideline Evaluation Trial
[77].
Statistical analysis
The primary clinical endpoint of this analysis is seven-day
PPA at three and six months. The primary process of care
endpoints are referral of patients to telephone counseling
(or other outpatient cessation counseling) and prescrip-
tion of recommended pharmacotherapy for smoking ces-
sation. To evaluate the relationship between the
intervention and these outcomes, we will use hierarchical
logistic regression to adjust for differences in potentially
confounding patient and nurse characteristics between
the baseline and intervention period cohorts. In these
analyses, each patient will be nested within his/her admit-
ting nurse, who will have primary responsibility for pro-
viding brief cessation counseling. To compare how the
two arms differ in time to first relapse after hospital dis-
charge, we will use Cox proportional-hazards survival
analysis methods with time to relapse as the outcome
[83]; in this analysis, intra-nurse correlation will be
accounted for by using the robust sandwich estimator
[84].
To evaluate the hypothesis that staff nurses will have
improved decisional balance scores and higher ratings of
self-efficacy in providing cessation counseling as a result
of the intervention, we will compare values of these meas-
ures obtained at the end of the intervention period to pre-
intervention values using a repeated measures ANOVA
with site included as a covariate (or a site-stratified Wil-
coxon signed-rank test, if the data are skewed or heavy-
tailed). To determine whether the intervention effect (if
any) is modified by nurses' perceptions of their work, we
will check the interaction between treatment and nurse
ratings of professional status and adequacy of staffing.Implementation Science 2009, 4:58 http://www.implementationscience.com/content/4/1/58
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We will use an intent-to-treat approach in which patients
are analyzed according to the period in which they were
enrolled. In our analysis of three- and six-month cessation
rates, those who are lost to follow-up will be considered
failures (i.e., still smoking). Using this approach, how-
ever, some bias may be introduced on account of inform-
ative censoring (even if the pattern of missingness is
evenly distributed across baseline and intervention peri-
ods). For this reason, we will also conduct analyses to
examine the patterns of missingness, and will perform
sensitivity analyses to compare intervention effects under
a range of assumptions regarding the mechanism of miss-
ingness [85,86]. All tests will be two-sided and will use a
p-value of 0.05 for statistical significance. To fit the hierar-
chical models, we will use SAS (PROC GLIMMIX).
Approach to qualitative analysis
Interview and focus group transcripts will be imported
into NVivo, a qualitative data management and analysis
software package. Descriptive content analysis will be
used to characterize inductively the issues raised by study
participants [87,88]; this process will be performed sepa-
rately for patients and nurses. Two reviewers, trained in
qualitative research methods, will read the transcripts
twice to identify pertinent issues and to construct a provi-
sional coding structure before actual coding commences.
The two reviewers will then code the transcripts by high-
lighting units of text that correspond to specific issues,
including those reflected in the provisional coding struc-
ture. Inter-rater reliability for key issues will be deter-
mined. Similar issues will be grouped together under
overarching domains. Domain characteristics, including
universality (across all informants), idiosyncrasy (unique
to one or two informants), and depth (types and richness
of subcategories), will be assessed and descriptive state-
ments about each domain will be developed using the
patients' words. Reviewers will pay close attention to
minority opinions that deviate from the dominant themes
and emerging hypotheses [89].
Cost effectiveness analysis
We will determine the cost-effectiveness ratio for the study
intervention from the perspective of the VA health care
system. We will account for cessation-related costs
incurred during the initial hospitalization and six-month
follow-up period in order to estimate the short-term incre-
mental cost per self-reported quitter:
where costint and costb equal the average total direct VA
resource cost for the intervention and the control groups,
respectively, nint is the number of patients exposed to the
intervention, and qint and qb are the six-month quit rates
in the intervention and baseline periods, respectively. The
denominator reflects change in the number of patients
quitting as a result of the intervention. The numerator
reflects the change in VA direct costs as a result of the inter-
vention.
Costs related to implementation will include the follow-
ing: time required for focus groups, initial training, and
feedback sessions (both for project staff and nursing
staff); nurse training materials, including internet tutorial;
time required for CPRS programming to develop nursing
reminders and prescription templates; and estimated time
spent by peer leaders in coaching staff nurses. We will also
include the salary of the full-time central research coordi-
nator and the salary support for the external nurse facilita-
tor, who will provide technical support for peer leaders
and nursing staff at all sites. To calculate the costs related
to delivery of smoking cessation services, we will estimate
the time expended on bedside counseling of smokers by
staff nurses, and then multiply this quantity by the aver-
age hourly salaries (including benefits) of VA nursing
staff, based on VA Human Resources data. We will also
track the time spent on telephone counseling, and esti-
mate these costs by multiplying the hourly salary of a quit
line counselor by the number of hours spent on telephone
counseling. The costs of pharmacotherapy will be based
on the quantity dispensed and the average wholesale price
for each product (generic transdermal NRT, bupropion,
and/or second-line drug therapies). We will also include
the costs of patient education materials (brochures and
educational video). For patients in each period, we will
estimate the cost of outpatient visits for cessation coun-
seling and/or smoking cessation pharmacotherapy
(including management of adverse reactions) during six-
month follow-up (by identifying cessation-related office
visits and multiplying by the average cost for a physician
visit).
To assess the robustness of the incremental cost per quit-
ter to changes in effectiveness, we will perform one-way
sensitivity analyses over plausible ranges of cost parame-
ters and the six-month quit rate. The uncertainty of the
incremental cost per quitter will also be estimated using
non-parametric bootstrapping (with 1,000 replications),
based on random sampling with replacement of a number
of participants in the trial [90].
Discussion
Although it is generally accepted that RCTs provide the
highest level of evidence in health care research, randomi-
zation in the current study is neither feasible nor accepta-
ble to study participants [24]. Moreover, RCTs are not
always the best study design for evaluation of the imple-
mentation of complex interventions, which typically
include multiple components, target multiple outcomes,
or aim to achieve outcomes that are difficult to influence
CE ratio  =  (cost -cost )/n (q -q ) int b int b intImplementation Science 2009, 4:58 http://www.implementationscience.com/content/4/1/58
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[91]. Using a quasi-experimental design, this study will fill
an important gap in the evidence base for smoking cessa-
tion in hospitalized patients, as the effectiveness of brief
bedside counseling combined with sustained relapse pre-
vention is unclear. The two studies that combined brief
inpatient counseling with sustained relapse prevention
were limited by insufficient power [92], lack of data on
the extent to which the relapse prevention component
was implemented [92], and failure to include pharmaco-
therapy as part of intervention [93].
Limitations of the proposed study design deserve com-
ment. Pre-post changes in outcome may be attributable to
'history' (the influence of events during the study that
affect the study outcomes) or 'maturation' (the change of
staff performance during the study related to the evolu-
tion of clinical skills) [25]. Potential Hawthorne effects
should be minimized by employing a sufficiently long
intervention period (six months). We will check for any
time-related changes in cessation counseling or patients'
intention to quit during the enrollment period in each
hospital. This will allow us to closely monitor any secular
trends (e.g., release of new smoking cessation aids,
changes in hospital policies) that might impact upon
delivery of cessation counseling or cessation outcomes. In
addition, we will account for any confounder variables
that show significant imbalances between baseline and
intervention periods in multivariable analyses.
This project directly addresses one of the key recommen-
dations to emerge from the VA Large Health Study: 'We
must find ways to identify and target those ready to quit
using tobacco so that limited resources have greater effect
[2].' If the study intervention is shown to be effective, it
will provide insights on how the CCM can be applied to
promote implementation of smoking cessation guidelines
in hospitals, and more generally, how to improve the con-
tinuity of preventive services as patients make the transi-
tion from the hospital to outpatient setting. The results of
this research can be used by clinicians, quality managers,
and VA decision makers to improve the quality of smok-
ing cessation services (above and beyond 'ask' and 'advise'
performance measures) [94,95]. If the study intervention
leads to a 7% increase in quit rates, this would result in
7,000 new non-smokers annually if implemented system-
wide (of the approximately 100,000 smokers who are
admitted to VA hospitals annually).
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